Youre never locked inyou can switch options anytime based on availability or preference
IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a recombinant analog of human IGF-1 with an 83-amino-acid sequence and an N-terminal extension that extends its half-life to approximately 2030 hours compared to endogenous IGF-1's 10-minute half-life
Germline pathogenic mutations in BAP1 result in a cancer predisposition syndrome, with increased risks of cutaneous and uveal melanoma, renal cell carcinoma, mesothelioma, and other cancers [79,80,81]
A provider should review these alongside oxidative stress markers to determine whether antioxidant support is clinically justified for your specific metabolic profile
The medication has a boxed warning from the FDA regarding the risk of thyroid C-cell tumors found in rodent studies, so we take this very seriously
In a trial of 21 healthy seniors confined to bed rest for 10 days, it was well-tolerated and demonstrated an ability to reduce muscle atrophy compared to a placebo